Jupiter Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Jupiter Asset Management’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-13,128	Closed	-$367K	–	411
2022 Q4	$367K	Buy	13,128 +2,061	+19%	+$59.8K	0.01%	423
2022 Q3	$311K	Sell	11,067 -2,831	-20%	-$92.4K	﹤0.01%	475
2022 Q2	$483K	Hold	13,898	–	–	0.01%	491
2022 Q1	$499K	Buy	+13,898	New	+$394K	0.01%	446

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

Jupiter Asset Management's AMPH Position: Q1 2023 in Review

Jupiter Asset Management sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2023, closing a stake of 13,128 shares — an estimated $367K sold.

Jupiter Asset Management first reported a position in AMPH in Q1 2022 and held it in 4 quarters. The position peaked at $499K in Q1 2022. 218 funds tracked by Wall St. Rank hold AMPH as of Q1 2023.

Jupiter Asset Management reported no remaining Amphastar Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
Jupiter Asset Management sold 13,128 Amphastar Pharmaceuticals shares in Q1 2023, an estimated $367K.
Jupiter Asset Management first reported a position in Amphastar Pharmaceuticals in Q1 2022 and held it in 4 quarters.
Jupiter Asset Management's Amphastar Pharmaceuticals position peaked at $499K in Q1 2022.
218 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2023.

Based on Jupiter Asset Management's 13F filing for Q1 2023, filed 10 May 2023.